Skip to main content

Table 10 Characteristics of the drug response multi-omics data set

From: A fair experimental comparison of neural network architectures for latent representations of multi-omics for drug response prediction

Drug

Resource

Number of Samples

Usage

Cetuximab

GDSC

856 (NR:735, R:121)

Train & test

Cisplatin

GDSC

829 (NR:752, R:77)

Train & test

Docetaxel

GDSC

829 (NR:764, R:65)

Train & test

Erlotinib

GDSC

362 (NR:298, R:64)

Train & test

Gemcitabine

GDSC

844 (NR:790, R:54)

Train & test

Paclitaxel

GDSC

389 (NR:363, R:26)

Train & test

Cetuximab

PDX

60 (NR:55, R:5)

External test

Cisplatin

TCGA

66 (NR:6, R:60)

External test

Docetaxel

TCGA

16 (NR:8, R:8)

External test

Erlotinib

PDX

21 (NR:18, R:3)

External test

Gemcitabine

PDX

25 (NR:18, R:7)

External test

Gemcitabine

TCGA

57 (NR:36, R:21)

External test

Paclitaxel

PDX

43 (NR:38, R:5)

External test

  1. NR, non-responder; R, responder